BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 32744360)

  • 1. Association between scanning frequency of flash glucose monitoring and continuous glucose monitoring-derived glycemic makers in children and adolescents with type 1 diabetes.
    Suzuki J; Urakami T; Yoshida K; Kuwabara R; Mine Y; Aoki M; Morioka I
    Pediatr Int; 2021 Feb; 63(2):154-159. PubMed ID: 32744360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individualization of recommendations from the international consensus on continuous glucose monitoring-derived metrics in Japanese children and adolescents with type 1 diabetes.
    Urakami T; Yoshida K; Kuwabara R; Mine Y; Aoki M; Suzuki J; Morioka I
    Endocr J; 2020 Oct; 67(10):1055-1062. PubMed ID: 32565500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of "Time below Range" as a Glycemic Marker Derived from Continuous Glucose Monitoring in Japanese Children and Adolescents with Type 1 Diabetes.
    Urakami T; Yoshida K; Kuwabara R; Mine Y; Aoki M; Suzuki J; Morioka I
    Horm Res Paediatr; 2020; 93(4):251-257. PubMed ID: 32950993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of flash glucose-sensing technology (FreeStyle Libre) in youth with type 1 diabetes: AWeSoMe study group real-life observational experience.
    Landau Z; Abiri S; Gruber N; Levy-Shraga Y; Brener A; Lebenthal Y; Barash G; Pinhas-Hamiel O; Rachmiel M
    Acta Diabetol; 2018 Dec; 55(12):1303-1310. PubMed ID: 30171412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent scanning using flash glucose monitoring contributes to better glycemic control in children and adolescents with type 1 diabetes.
    Urakami T; Yoshida K; Kuwabara R; Mine Y; Aoki M; Suzuki J; Morioka I
    J Diabetes Investig; 2022 Jan; 13(1):185-190. PubMed ID: 34143544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between key continuous glucose monitoring-derived metrics and specific cognitive domains in patients with type 2 diabetes mellitus.
    Dong S; Wang L; Zhao C; Zhang R; Gao Z; Jiang L; Guo Y; Zhou H; Xu S
    BMC Neurol; 2023 May; 23(1):200. PubMed ID: 37210479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flash glucose monitoring system in patients with type 1 diabetes in healthcare center in Brazil: real world data from a short-term prospective study.
    Matheus ASM; Pascoal JBF; Cabizuca CA; Tannus LRM; Guimarães RS; Mattos DMF; Cobas RA
    Arch Endocrinol Metab; 2023 Mar; 67(3):289-297. PubMed ID: 36468924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of flash glucose monitoring in pregnant women with poorly controlled pregestational diabetes (FlashMom): A randomized pilot study.
    Tumminia A; Milluzzo A; Festa C; Fresa R; Pintaudi B; Scavini M; Vitacolonna E; Napoli A; Sciacca L
    Nutr Metab Cardiovasc Dis; 2021 Jun; 31(6):1851-1859. PubMed ID: 33975741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Glycemic Variability Is Associated with Worse Continuous Glucose Monitoring Metrics in Children and Adolescents with Type 1 Diabetes.
    Piona C; Marigliano M; Mozzillo E; Di Candia F; Zanfardino A; Iafusco D; Maltoni G; Zucchini S; Delvecchio M; Maffeis C
    Horm Res Paediatr; 2021; 94(9-10):369-373. PubMed ID: 34915493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flash Glucose Monitoring in Israel: Understanding Real-World Associations between Self-Monitoring Frequency and Metrics of Glycemic Control.
    Eldor R; Roitman E; Merzon E; Toledano Y; Alves C; Tsur A
    Endocr Pract; 2022 May; 28(5):472-478. PubMed ID: 35167952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flash glucose monitoring reduces glycemic variability and hypoglycemia: real-world data from Spain.
    Gomez-Peralta F; Dunn T; Landuyt K; Xu Y; Merino-Torres JF
    BMJ Open Diabetes Res Care; 2020 Mar; 8(1):. PubMed ID: 32198165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of the CGM metric of time in range in children and adolescents with type 1 diabetes.
    Urakami T
    Endocr J; 2022 Sep; 69(9):1035-1042. PubMed ID: 36002301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycaemic control during the lockdown for COVID-19 in adults with type 1 diabetes: A meta-analysis of observational studies.
    Garofolo M; Aragona M; Rodia C; Falcetta P; Bertolotto A; Campi F; Del Prato S; Penno G
    Diabetes Res Clin Pract; 2021 Oct; 180():109066. PubMed ID: 34563586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Interstitial Fluid Glucose Levels Obtained by Continuous Glucose Monitoring and Flash Glucose Monitoring in Patients With Type 2 Diabetes Mellitus Undergoing Hemodialysis.
    Yajima T; Takahashi H; Yasuda K
    J Diabetes Sci Technol; 2020 Nov; 14(6):1088-1094. PubMed ID: 31625413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Assessment of Clinical Continuous Glucose Monitoring Targets for Older and High-Risk People Living with Type 1 Diabetes.
    O'Neal DN; Cohen O; Vogrin S; Vigersky RA; Jenkins AJ;
    Diabetes Technol Ther; 2023 Feb; 25(2):108-115. PubMed ID: 36315189
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of aging and frailty on inpatient glycemic control by continuous glucose monitoring in patients with type 2 diabetes.
    Idrees T; Zabala ZE; Moreno EM; Gerges A; Urrutia MA; Ruiz JG; Vaughan C; Vellanki P; Pasquel FJ; Peng L; Umpierrez GE
    Diabetes Res Clin Pract; 2023 Apr; 198():110603. PubMed ID: 36871877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Continuous Glucose Monitoring on Metrics of Glycemic Control in Diabetes: A Systematic Review With Meta-analysis of Randomized Controlled Trials.
    Maiorino MI; Signoriello S; Maio A; Chiodini P; Bellastella G; Scappaticcio L; Longo M; Giugliano D; Esposito K
    Diabetes Care; 2020 May; 43(5):1146-1156. PubMed ID: 32312858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Glycemia Risk Index with Time in Range for Assessing Glycemic Quality.
    Kim JY; Yoo JH; Kim JH
    Diabetes Technol Ther; 2023 Dec; 25(12):883-892. PubMed ID: 37668665
    [No Abstract]   [Full Text] [Related]  

  • 19. The Benefits of Utilizing Continuous Glucose Monitoring of Diabetes Mellitus in Primary Care: A Systematic Review.
    Kieu A; King J; Govender RD; Östlundh L
    J Diabetes Sci Technol; 2023 May; 17(3):762-774. PubMed ID: 35100891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGM-based remote intervention for adults with type 1 diabetes: The FRIEND randomized clinical trial.
    Lee J; Lee MH; Park J; Kim KS; Kim SK; Cho YW; Han HW; Song YS
    Front Endocrinol (Lausanne); 2022; 13():1054697. PubMed ID: 36506077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.